Cargando…

Loss of KLF14 triggers centrosome amplification and tumorigenesis

Centrosome amplification is frequent in cancer, but the underlying mechanisms remain unclear. Here we report that disruption of the Kruppel-like factor 14 (KLF14) gene in mice causes centrosome amplification, aneuploidy and spontaneous tumorigenesis. Molecularly, KLF14 functions as a transcriptional...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Guangjian, Sun, Lianhui, Shan, Peipei, Zhang, Xianying, Huan, Jinliang, Zhang, Xiaohong, Li, Dali, Wang, Tingting, Wei, Tingting, Gu, Xiaoyang, Yao, Liangfang, Xuan, Yang, Hou, Zhaoyuan, Cui, Yongping, Cao, Liu, Li, Xiaotao, Zhang, Shengping, Wang, Chuangui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Pub. Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600754/
https://www.ncbi.nlm.nih.gov/pubmed/26439168
http://dx.doi.org/10.1038/ncomms9450
Descripción
Sumario:Centrosome amplification is frequent in cancer, but the underlying mechanisms remain unclear. Here we report that disruption of the Kruppel-like factor 14 (KLF14) gene in mice causes centrosome amplification, aneuploidy and spontaneous tumorigenesis. Molecularly, KLF14 functions as a transcriptional repressor of Plk4, a polo-like kinase whose overexpression induces centrosome overduplication. Transient knockdown of KLF14 is sufficient to induce Plk4-directed centrosome amplification. Clinically, KLF14 transcription is significantly downregulated, whereas Plk4 transcription is upregulated in multiple types of cancers, and there exists an inverse correlation between KLF14 and Plk4 protein expression in human breast and colon cancers. Moreover, KLF14 depletion promotes AOM/DSS-induced colon tumorigenesis. Our findings reveal that KLF14 reduction serves as a mechanism leading to centrosome amplification and tumorigenesis. On the other hand, forced expression of KLF14 leads to mitotic catastrophe. Collectively, our findings identify KLF14 as a tumour suppressor and highlight its potential as biomarker and therapeutic target for cancer.